VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
Milestone: World's First Extracellular Protein Degrader Enters Phase III Clinical Trial for IgA Nephropathy
Milestone: World's First Extracellular Protein Degrader Enters Phase III Clinical Trial for IgA Nephropathy
Jun 12, 2026 09:01 CST Updated 10:55
Share:
